CXCL12 and neoplasm: To reconfirm that anti-IL-17A treatment indeed reduces the level of SDF-1 in the arthritic mice prior to the development of tumor, we treated non-tumor bearing arthritic mice (C57BL/6 mice injected with CII) with the anti-IL-17A antibody.